Karyopharm Therapeutics
KPTI
$1.10
Share price
3.77%
Change (1 day)
-71.43%
Change (1 year)
Categories
Karyopharm Therapeutics (KPTI) - P/B ratio
P/B ratio as of April 2024 : -0.9406
According to Karyopharm Therapeutics
's latest financial reports the company has a price-to-book ratio of -0.9406.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Karyopharm Therapeutics - P/B ratio (from 2013 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -0.7274 | -96.85% |
| 2022-12-31 | -23.1 | 279.04% |
| 2021-12-31 | -6.10 | -127.05% |
| 2020-12-31 | 22.5 | -10.47% |
| 2019-12-31 | 25.2 | 709.1% |
| 2018-12-31 | 3.11 | -11.06% |
| 2017-12-31 | 3.50 | 46.41% |
| 2016-12-31 | 2.39 | -0.25% |
| 2015-12-31 | 2.40 | -59.52% |
| 2014-12-31 | 5.92 | 35.22% |
| 2013-12-31 | 4.38 | |
| 2012-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | 4.79 | -609.67% | 🇺🇸 USA |
 Merck MRK | 8.76 | -1,031.10% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 5.47 | -681.28% | 🇺🇸 USA |
 Exelixis EXEL | 3.09 | -428.53% | 🇺🇸 USA |